Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $ ...
PharmiWeb44m
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...
Stereotaxis, Inc. (AMEX:STXS) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 Stereotaxis, Inc. misses on earnings expectations. Reported EPS is $-0.09 EPS, ...
Opinion
Rappler58mOpinion
SEC revokes license of Surity Cash for ‘unfair debt collection practices’
MANILA, Philippines – The Securities and Exchange Commission (SEC) has canceled the license of an online lending application (OLA) for what it described as unfair debt collection practices.
Windtree Announces Istaroxime Notice of Allowance from the U.S. Patent and Trademark Office for Acute Heart Failure
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...